Maribel
Maribel Diaz-Ricart, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100167261 | PLATELET STABILIZATION - Provided are methods for stabilizing mean platelet component and/or platelets in a sample comprising combining said sample with EDTA, a second anticoagulant, and one or more kinase inhibitors. Also provided are compositions for stabilizing a sample comprising platelets, and kits for storing a platelet sample. | 07-01-2010 |
Maribel Figuera, Tora (lleida) ES
Patent application number | Description | Published |
---|---|---|
20110158545 | APPARATUS AND METHOD OF MATCHING SYMBOLS IN A TEXT IMAGE CODING AND DECODING SYSTEM - An apparatus of a text image coding and decoding system includes a matching unit to compute a first distance between a symbol of a text image with a reference symbol of a symbol dictionary, to determine whether the symbol matches with the reference symbol according to the first distance and a first reference, and to compute a second distance between the one of the symbols with the reference symbol if the symbol does not match with the reference symbol according to the first distance and the first reference, and to determine whether the symbol matches with the reference symbol according to the second distance and a second reference. | 06-30-2011 |
Maribel Gallegos-Candela, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20130210031 | DETECTION OF ADENYLATE CYCLASE - One major problem in diagnosis methods presently available for anthrax is that these methods require several days to produce a result, are rendered unusable after antibiotic use, or are not quantifiable. The only existing treatment for anthrax requires administration soon after infection at a time when patients are exhibiting only mild flu-like symptoms. Thus, by the time a diagnosis is made a patient may be days beyond the time when treatment would be effective. The present invention reduces diagnosis time to as little as four hours providing same day identification of anthrax radically increasing the odds of delivering proper treatment and patient recovery. The rapid identification of anthrax edema factor activity exhibited by the invention is also amenable to in vivo screening protocols for the discovery and development of anthrax vaccines, anti-toxins and edema factor inhibitors. The invention isolates and concentrates edema factor and edema toxin from nearly any sample. By capitalizing on the adenylate cyclase activity of edema factor the invention amplifies output signals producing reliable detection of low concentrations of edema factor previously unachievable. The invention involves novel purification and detection techniques and substrates for rapid, reproducible, and quantitative measurements of anthrax edema factor, and other adenylate cyclases in biological samples. | 08-15-2013 |
Maribel Guerra Vallespi, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20090221508 | IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES - The present invention is related to the development of peptides derived from the sequence HYRIKPTFRRLKWKKYKGKFW, showing aminoacids substitutions, these peptides unable to bind to the lipopolysaccharide and bearing anti-tumoral and immunomodulatory capacities. These peptides alone or in combination are useful to treat cancer, and also in synergy with conventional therapies. | 09-03-2009 |
20120135021 | CELL PENETRATING PEPTIDES AND ITS USE FUSED TO BIOMOLECULES WITH THERAPEUTIC ACTION - The present invention relates to use of a new cell penetrating peptides (CPP) and in particular to the region 32-51 of protein | 05-31-2012 |
Maribel Guerra Vallespi, La Habana CU
Patent application number | Description | Published |
---|---|---|
20130224313 | CANCER THERAPY METHOD - This invention describes a method for treating cancer by increasing the nuclear localization of the COMMD1 protein, which is associated with decreasing or blocking the proliferation of the cancer cell. The invention is also related to the use of agents that increase nuclear localization of the COMMD1 protein, in the manufacture of a medicament for cancer therapy. These agents can be peptides or proteins, among other compounds. The invention is also related to the optimization of a peptide, coming from the sequence HARIKPTFRRLKWKKYKGKFW, to increase the nuclear localization of the protein COMMD, and thus, to increase the antitumor effect of this peptide. | 08-29-2013 |
20140206621 | Cancer Therapy Method - This invention describes a method for treating cancer by increasing the nuclear localization of the COMMD1 protein, which is associated with decreasing or blocking the proliferation of the cancer cell. The invention is also related to the use of agents that increase nuclear localization of the COMMD1 protein, in the manufacture of a medicament for cancer therapy. These agents can be peptides or proteins, among other compounds. The invention is also related to the optimization of a peptide, coming from the sequence HARIKPTFRRLKWKKYKGKFW, to increase the nuclear localization of the protein COMMD, and thus, to increase the antitumor effect of this peptide. | 07-24-2014 |